Growth Metrics

Odyssey Health (ODYY) EBT Margin (2014 - 2016)

Odyssey Health's quarterly EBT Margin came in at 246.36% in Q3 2016, down 577.3% quarter-over-quarter from 36.37% in Q2 2016.

Odyssey Health has reported EBT Margin for 3 years, with the latest figure at 246.36% in Q3 2016.

  • For the quarter ending Q3 2016, EBT Margin changed N/A year-over-year to 246.36%; the trailing twelve-month figure through Apr 2017 stood at 1136.24% (down 81028.0% YoY), and the FY2016 full-year result was 229.94%, down 16746.0% from the prior year.
  • EBT Margin for Q3 2016 stood at 246.36%, down from 36.37% in the prior quarter.
  • The five-year high for EBT Margin was 31.44% in Q4 2014, with the low at 246.36% in Q3 2016.
  • Average EBT Margin over 3 years is 120.09%, with a median of 50.2% recorded in 2015.
  • Peak annual rise in EBT Margin reached 19972 bps in 2016, while the deepest fall reached 19972 bps in 2016.
  • Tracing ODYY's EBT Margin over 3 years: stood at 31.44% in 2014, then slumped by 651 bps to 236.09% in 2015, then declined by 4 bps to 246.36% in 2016.
  • The last three EBT Margin figures came in at 246.36% (Q3 2016), 36.37% (Q2 2016), and 236.09% (Q2 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.98%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.12%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 15.57%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.84%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.17%
10 Odyssey Health - - - -

Historic Data

Download Data 🔒
DateValue
Jul 31, 2016 -246.36%
Apr 30, 2016 -36.37%
Apr 30, 2015 -236.09%
Jan 31, 2015 -50.20%
Oct 31, 2014 -31.44%